ArticleMultiple sclerosis journal - experimental, translational and clinical

Satisfaction with alemtuzumab in relapsing multiple sclerosis patients: Results from the real-world PRO-ACT study.

Sibyl Wray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.